Script

NEW PROSTATE CANCER STUDY
Ilana Mendelow, MD, Urologist, Baylor Scott & White Health

{**ON CAM**}

A NEW STUDY OUT OF THE UNITED KINGDOM SAYS MEN DIAGNOSED WITH THE MOST COMMON TYPE OF PROSTATE CANCER CAN OFTEN DELAY AGGRESSIVE TREATMENTS OR SURGERY. BUT, NOT ALL DOCTORS AGREE. ?

{**TAKE VO**}
UROLOGIST ILANA MENDELOW SAYS MEN ARE OFTEN SCREENED VIA BLOOD TESTING FOR SOMETHING CALLED A 'P-S-A' LEVEL. ELEVATED P-S-A LEVELS CAN INDICATE THE PRESENCE OF PROSTATE CAN- CER. BUT SHE SAYS THE PRESENCE OF A HIGHER P-S-A LEVEL DOESN'T NECESSA- RILY WARRANT ACTION.

{**TAKE SOT**}

Ilana Mendelow, MD
Baylor Scott & White Health

"We know that not all prostate cancers are life-threatening. Some can be very slow gro- wing. Just because someone has an elevated PSA doesn't mean we're automatically going to go to more invasive methods."

{**ON CAM**}

SINCE PROSTATE CANCER IS THE SECOND MOST COMMON CAUSE OF CAN- CER DEATH FOR MEN IN THE US, DOCTOR MENDELOW SAYS TIMELY TREAT- MENT IS STILL NEEDED FOR MORE AGGRESSIVE TYPES OF PROSTATE CAN- CER. BUT… AS THE LATEST STUDY INDICATES … FOR THE MAJORITY OF MEN … TAKING A 'WAIT AND SEE' APPROACH MAY BE AN OPTION.